$2.58
0.39%
Nasdaq, Oct 03, 10:16 pm CET
ISIN
CA22717L1013
Symbol
CRON

Cronos Group Inc Stock price

$2.58
+0.05 1.98% 1M
+0.80 44.94% 6M
+0.56 27.72% YTD
+0.34 15.18% 1Y
-0.35 11.95% 3Y
-2.66 50.76% 5Y
+2.42 1,463.64% 10Y
+2.42 1,463.64% 20Y
Nasdaq, Closing price Fri, Oct 03 2025
-0.01 0.39%
ISIN
CA22717L1013
Symbol
CRON
Industry

Key metrics

Basic
Market capitalization
$992.6m
Enterprise Value
$158.1m
Net debt
positive
Cash
$834.4m
Shares outstanding
383.8m
Valuation (TTM | estimate)
P/E
64.5 | negative
P/S
7.6 | 7.1
EV/Sales
1.2 | 1.1
EV/FCF
negative
P/B
0.9
Financial Health
Equity Ratio
91.2%
Return on Equity
3.9%
ROCE
-3.4%
ROIC
-12.8%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$130.3m | $140.8m
EBITDA
$-35.8m | $16.8m
EBIT
$-38.7m | $-18.0m
Net Income
$18.5m | $-5.9m
Free Cash Flow
$-9.4m
Growth (TTM | estimate)
Revenue
28.0% | 19.7%
EBITDA
43.5% | 130.1%
EBIT
42.6% | 69.8%
Net Income
132.2% | -114.3%
Free Cash Flow
-178.0%
Margin (TTM | estimate)
Gross
32.7%
EBITDA
-27.5% | 12.0%
EBIT
-29.7%
Net
14.2% | -4.2%
Free Cash Flow
-7.2%
More
EPS
$0.0
FCF per Share
$0.0
Short interest
1.5%
Employees
459
Rev per Employee
$260.0k
Show more

Is Cronos Group Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,001 stocks worldwide.

Cronos Group Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Cronos Group Inc forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Cronos Group Inc forecast:

Buy
86%
Hold
14%

Financial data from Cronos Group Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
130 130
28% 28%
100%
- Direct Costs 88 88
3% 3%
67%
43 43
156% 156%
33%
- Selling and Administrative Expenses 74 74
1% 1%
57%
- Research and Development Expense 3.99 3.99
14% 14%
3%
-36 -36
43% 43%
-27%
- Depreciation and Amortization 2.93 2.93
29% 29%
2%
EBIT (Operating Income) EBIT -39 -39
43% 43%
-30%
Net Profit 18 18
132% 132%
14%

In millions USD.

Don't miss a Thing! We will send you all news about Cronos Group Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Cronos Group Inc Stock News

Positive
The Motley Fool
4 days ago
Marijuana stocks are getting some attention this week following new interest from President Donald Trump.
Positive
Seeking Alpha
6 days ago
Cannabis stocks surged after Trump endorsed CBD for senior healthcare, citing its potential to revolutionize treatment and reduce healthcare costs. Shares of TLRY, CGC, CRON, and ACB soared double digits, with related ETFs MSOS and MJ also posting significant gains.
Positive
Proactive Investors
6 days ago
Cannabis stocks lit up Wall Street after Donald Trump backed a push to bring CBD under Medicare. The former president reposted a three-minute video from The Commonwealth Project, a campaign arguing that older Americans should have access to hemp-derived cannabidiol.
More Cronos Group Inc News

Company Profile

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Head office Canada
CEO Michael Gorenstein
Employees 459
Founded 2012
Website thecronosgroup.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today